News
In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight ...
2d
GlobalData on MSNChina’s clinical trial ecosystem takes centre stage in Suzhou this SeptemberThe inaugural Outsourcing in Clinical Trials & Clinical Trial Supply China conference will gather experts to discuss China's ...
2d
GlobalData on MSNClinical trial supply chains in the US navigate pharma tariffsThe 2025 Clinical Trial Supply West Coast conference will gather experts to discuss US trial operations in a shifting tariff ...
Clinical Trial Failure Isn’t an Inevitable Risk—It’s Insurable and Opening the Door to New Investors
Clinical trial failure insurance is turning biotech’s most costly risk into a manageable asset, opening new pathways for ...
Clinical trial updates in cancer care include a remote study in small cell lung cancer and new findings in ovarian, solid ...
1don MSN
A team led by Vanderbilt University and Vanderbilt University Medical Center biomedical engineers and surgeons has published ...
Colorectal cancer is the third most common cancer worldwide, resulting in 50,000 deaths annually in the U.S. alone.
Now, new clinical trial results suggest that an oral form of this medication may be coming soon—and the results so far are ...
The Cancer Vaccine Launch Pad – a partnership between NHS England, the Government and BioNTech – has already helped refer ...
22h
News Medical on MSNEarly clinical trial supports MASL as a targeted oral cancer treatmentRowan University and Sentrimed, a clinical-stage biopharmaceutical company focused on developing safer, orally dosed oncology therapies, today announced results from a National Cancer Institute (NCI) ...
Company opts not to advance VX-993 into pivotal development after Phase II data show no statistically significant benefit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results